COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic …
C Ammitzbøll, MK Thomsen, LE Bartels… - ACR open …, 2024 - Wiley Online Library
Objective Rituximab (RTX)‐treated patients exhibit suboptimal responses to COVID‐19
vaccines. However, existing research primarily involves patients already receiving RTX …
vaccines. However, existing research primarily involves patients already receiving RTX …
The Future of COVID-19 for Patients With Immune-Mediated Inflammatory Diseases: Who Is at Risk?
C Calabrese - The Journal of Rheumatology, 2024 - jrheum.org
For the rheumatologist, one of the greatest challenges since the start of the coronavirus
disease 2019 (COVID-19) pandemic has been determining which of our patients are at …
disease 2019 (COVID-19) pandemic has been determining which of our patients are at …